tradingkey.logo

Indivior PLC

INDV
36.532USD
+0.372+1.03%
交易中 美东报价延迟15分钟
4.57B总市值
37.14市盈率 TTM

Indivior PLC

36.532
+0.372+1.03%

关于 Indivior PLC 公司

Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.

Indivior PLC简介

公司代码INDV
公司名称Indivior PLC
上市日期Dec 24, 2014
CEOCiaffoni (Joseph J)
员工数量1030
证券类型Ordinary Share
年结日Dec 24
公司地址234 Bath Road
城市SLOUGH
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United Kingdom
邮编SL1 4EE
电话448043791090
网址https://www.indivior.com/en
公司代码INDV
上市日期Dec 24, 2014
CEOCiaffoni (Joseph J)

Indivior PLC公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--
Ms. Juliet Thompson
Ms. Juliet Thompson
Senior Non-Executive Independent Director
Senior Non-Executive Independent Director
9.63K
+150.00%
Dr. Keith Humphreys
Dr. Keith Humphreys
Non-Executive Independent Director
Non-Executive Independent Director
3.88K
+63.05%
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
760.00
--
Mr. Stuart (Tony) Kingsley
Mr. Stuart (Tony) Kingsley
Independent Non-Executive Director
Independent Non-Executive Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
256.00M
84.77%
Rest of World
46.00M
15.23%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 12月4日 周四
更新时间: 12月4日 周四
持股股东
股东类型
持股股东
持股股东
占比
Oaktree Capital Management, L.P.
7.00%
BlackRock Institutional Trust Company, N.A.
6.24%
Madison Avenue Partners LP
5.18%
Goldman Sachs & Company, Inc.
5.13%
Two Seas Capital LP
4.98%
其他
71.47%
持股股东
持股股东
占比
Oaktree Capital Management, L.P.
7.00%
BlackRock Institutional Trust Company, N.A.
6.24%
Madison Avenue Partners LP
5.18%
Goldman Sachs & Company, Inc.
5.13%
Two Seas Capital LP
4.98%
其他
71.47%
股东类型
持股股东
占比
Hedge Fund
33.71%
Investment Advisor/Hedge Fund
28.33%
Investment Advisor
17.97%
Research Firm
12.00%
Individual Investor
3.87%
Pension Fund
0.61%
Bank and Trust
0.32%
Family Office
0.27%
Insurance Company
0.04%
其他
2.88%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
372
118.02M
94.53%
+2.51M
2025Q2
354
123.13M
98.21%
+4.02M
2025Q1
380
119.99M
96.15%
-1.70M
2024Q4
382
116.83M
93.64%
-10.43M
2024Q3
369
117.73M
91.72%
-15.91M
2024Q2
352
119.29M
90.10%
-8.99M
2024Q1
341
129.79M
96.57%
+3.79M
2023Q4
322
124.43M
92.28%
+2.93M
2023Q3
321
114.40M
84.40%
+17.06M
2023Q2
296
115.50M
83.90%
+12.51M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Oaktree Capital Management, L.P.
11.01M
8.82%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.04M
4.04%
+5.03M
+68055.48%
Jun 30, 2025
Madison Avenue Partners LP
7.92M
6.35%
+130.09K
+1.67%
Jun 30, 2025
Two Seas Capital LP
10.33M
8.28%
-1.33M
-11.43%
Sep 03, 2025
Deerfield Management Company, L.P.
10.57M
8.47%
--
--
Jun 30, 2025
Newtyn Management, LLC
2.61M
2.09%
+956.08K
+57.91%
Jun 30, 2025
The Vanguard Group, Inc.
5.63M
4.51%
+1.02M
+22.15%
Jun 30, 2025
Sirovich (Matthew I.)
3.42M
2.74%
+249.62K
+7.87%
Sep 30, 2024
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Lattice Hartford Multifactor Small Cap ETF
1.11%
ProShares Ultra Nasdaq Biotechnology
0.51%
Federated Hermes MDT Small Cap Core ETF
0.47%
Janus Henderson Small Cap Growth Alpha ETF
0.43%
First Trust Multi-Manager Small Cap Opportunities ETF
0.38%
Invesco Nasdaq Biotechnology ETF
0.36%
Franklin US Small Cap Multifactor Index ETF
0.32%
First Trust Active Factor Small Cap ETF
0.31%
Vanguard US Multifactor ETF
0.27%
Pacer US Small Cap Cash Cows ETF
0.26%
查看更多
Lattice Hartford Multifactor Small Cap ETF
占比1.11%
ProShares Ultra Nasdaq Biotechnology
占比0.51%
Federated Hermes MDT Small Cap Core ETF
占比0.47%
Janus Henderson Small Cap Growth Alpha ETF
占比0.43%
First Trust Multi-Manager Small Cap Opportunities ETF
占比0.38%
Invesco Nasdaq Biotechnology ETF
占比0.36%
Franklin US Small Cap Multifactor Index ETF
占比0.32%
First Trust Active Factor Small Cap ETF
占比0.31%
Vanguard US Multifactor ETF
占比0.27%
Pacer US Small Cap Cash Cows ETF
占比0.26%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Indivior PLC的前五大股东是谁?

Indivior PLC 的前五大股东如下:
Oaktree Capital Management, L.P.持有股份:11.01M,占总股份比例:8.82%。
BlackRock Institutional Trust Company, N.A.持有股份:5.04M,占总股份比例:4.04%。
Madison Avenue Partners LP持有股份:7.92M,占总股份比例:6.35%。
Two Seas Capital LP持有股份:10.33M,占总股份比例:8.28%。
Deerfield Management Company, L.P.持有股份:10.57M,占总股份比例:8.47%。

Indivior PLC的前三大股东类型是什么?

Indivior PLC 的前三大股东类型分别是:
Oaktree Capital Management, L.P.
BlackRock Institutional Trust Company, N.A.
Madison Avenue Partners LP

有多少机构持有Indivior PLC(INDV)的股份?

截至2025Q3,共有372家机构持有Indivior PLC的股份,合计持有的股份价值约为118.02M,占公司总股份的94.53%。与2025Q2相比,机构持股有所增加,增幅为-3.68%。

哪个业务部门对Indivior PLC的收入贡献最大?

在FY2025Q2,--业务部门对Indivior PLC的收入贡献最大,创收--,占总收入的--%。
KeyAI